Physician

Allan David Mineroff, M.D.

According to 2025 Medicare claims, Allan Mineroff, M.D. (NPI: 1134159858) practices dermatology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is PENNSYLVANIA DERMATOLOGY PARTNERS INC (NPI: 1023382918; TIN: 454600640) and primary practice location at 19446-1115.

Mineroff's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 920 traditional Medicare patients, billed 3,595 HCPCS/CPT codes, and received $178,119 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 596 prescription claims across 322 beneficiaries totaling $210,187 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 80 records totaling $1,115. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$110K$220K2015 Medicare payment: $176,719 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $201,681 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $160,965 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $159,563 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $180,802 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $148,593 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $220,230 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $181,619 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $154,035 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $178,119 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0133,868$176,719
20169924,157$201,681
20179083,527$160,965
20189023,224$159,563
20198983,540$180,802
20207762,946$148,593
20219113,962$220,230
20228733,642$181,619
20237933,139$154,035
20249203,595$178,119

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$127K$253K2015 Drug cost: $148,161 (USD; Tot_Drug_Cst)2016 Drug cost: $161,508 (USD; Tot_Drug_Cst)2017 Drug cost: $148,649 (USD; Tot_Drug_Cst)2018 Drug cost: $156,195 (USD; Tot_Drug_Cst)2019 Drug cost: $127,138 (USD; Tot_Drug_Cst)2020 Drug cost: $121,102 (USD; Tot_Drug_Cst)2021 Drug cost: $91,492 (USD; Tot_Drug_Cst)2022 Drug cost: $96,321 (USD; Tot_Drug_Cst)2023 Drug cost: $253,134 (USD; Tot_Drug_Cst)2024 Drug cost: $210,187 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015290524$148,161
2016295566$161,508
2017275490$148,649
2018272516$156,195
2019289548$127,138
2020260552$121,102
2021373733$91,492
2022361692$96,321
2023315595$253,134
2024322596$210,187

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more758892$67
11102Biopsy of related skin growth, first growth470554$66
11103Biopsy of related skin growth, each additional growth184323$38
17000Destruction of precancer skin growth, 1 growth291353$36
17003Destruction of precancer skin growth, 2-14 growths180887$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
StelaraUstekinumab141,064$186,429
FluorouracilFluorouracil702,072$3,935
MetronidazoleMetronidazole431,335$2,161
KetoconazoleKetoconazole882,961$1,838
Clobetasol PropionateClobetasol Propionate521,318$1,779

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.80$1,115Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Allan David Mineroff, M.D.?

Tedicare shows public-source Medicare data for Allan David Mineroff, M.D. (NPI 1134159858), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allan David Mineroff, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Allan David Mineroff, M.D.?

Allan David Mineroff, M.D. is linked to PENNSYLVANIA DERMATOLOGY PARTNERS INC (billing NPI 1023382918) in the available physician profile data.

Does Allan David Mineroff, M.D. have Open Payments data?

Allan David Mineroff, M.D. has 80 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.